arrow
M

Masao Toyoda

Department of Internal Medicine
H指数:32
被引数:6,053

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of sacubitril/valsartan according to daily salt intake and comparison with thiazide add-on treatment in patients with uncontrolled hypertension

根据每日盐摄入量的沙库必利/缬沙坦的效果及与噻嗪类利尿剂加用治疗在未控制高血压患者中的比较

2025-11-140
PRE
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study)

鲁泽ogliptin对伴有肾功能受损的2型糖尿病患者的肾功能保护作用的疗效:一项随机开放标签临床试验(RESOLUTION研究)

2025-10-090
OAAI
Comparison between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension in Japan

在日本未控制高血压患者中,沙库巴曲/缬沙坦与噻嗪类利尿剂的比较

2025-05-190
PRE
The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study
2025-02-170
OA
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study

成人1型糖尿病患者血红蛋白糖化指数的相关因素: FGM-日本研究

2023-02-146
OAAI
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study

canagliflozin在日本人群中2型糖尿病和微量白蛋白尿患者中的作用的基本原理,设计和基线特征: canpion研究

2022-05-181
OAAI
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

钠-葡萄糖共转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂对肾脏预后的比较

2022-03-018
PRE
Genome-wide association studies identify two novel loci conferring susceptibility to diabetic retinopathy in Japanese patients with type 2 diabetes

全基因组关联研究确定了两个赋予日本2型糖尿病患者糖尿病视网膜病变易感性的新基因座

2021-02-1920
OAAI
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
2021-02-0111
PREAI
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models
2020-07-107
OAAI